FLUIFORT SYRUP SACHETS 6 SACHETS
search

FLUIFORT SYRUP SACHETS 6 SACHETS

  • 02383414
Features:


Mucolytic action of the upper and lower airways.


Concentrated formulation.


1 sachet per day.


Promotes the removal of mucus.


Not suitable for children under 11 years.


















info_outline View product sheet
Final Price €9.00
Quantity
check_circle Available (17 Items)
48h
  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service

Drugs Others products at unbeatable price

FLUIFORT SYRUP SACHETS 6 SACHETS



































TECHNICAL SHEET RCP DRUGS FROM DATABASE







[su_spoiler title = "MEDICINAL NAME"style =" fancy "icon =" chevron-circle "] Fluifort 2.7 g / 10 ml syrup. [/ su_spoiler]

[su_spoiler title = "QUALITATIVE AND QUANTITATIVE COMPOSITION"style =" fancy "icon =" chevron-circle "] A 10 ml sachet of 27 syrup% contains:

active ingredient: carbocysteine lysine salt monohydrate equal to 2.7 g of carbocysteine lysine salt.

Excipients: methyl para-hydroxybenzoate, propyl para-hydroxybenzoate, sorbitol.

For the full list of excipients, see section 6.1. [/ Su_spoiler]

[su_spoiler title = "PHARMACEUTICAL FORM"style =" fancy "icon =" chevron-circle "] Syrup. [/ su_spoiler]

[su_spoiler title = "THERAPEUTIC INDICATIONS"style =" fancy "icon =" chevron-circle "] Mucolytic, fluidifying in acute and chronic respiratory diseases. [/ su_spoiler]

[su_spoiler title = "DOSAGE AND METHOD OF ADMINISTRATION"style =" fancy "icon =" chevron-circle "] 1 sachet per day.

Fluifort 2.7 g / 10 ml syrup, due to its innovative packaging, ensures precision in dosage, hygiene, practicality and ease of intake and is particularly suitable for diseases in the acute phase for which short-term treatment is required.

In consideration of the pharmacokinetic characteristics, the recommended posology can be maintained even in patients with renal and hepatic insufficiency.

Duration of treatment: carbocysteine lysine salt monohydrate can also be used for prolonged periods, in this case it is advisable to follow the advice of the doctor. [/ Su_spoiler]

[su_spoiler title = "CONTRAINDICATIONS"style =" fancy "icon =" chevron-circle "] Hypersensitivity to the active substance or to any of the excipients. Gastroduodenal ulcer. Pregnancy and lactation. The drug is contraindicated in pediatric patients under 11 years. [/ su_spoiler]

[su_spoiler title = "WARNINGS AND PRECAUTIONS FOR USE"style =" fancy "icon =" chevron-circle "] No addiction or addiction phenomena are known.

The medicine contains methyl para-hydroxybenzoate and propyl para-hydroxybenzoate, which are known to cause urticaria. In general, para-hydroxybenzoates can cause delayed reactions, such as contact dermatitis and rarely immediate reactions with manifestation of urticaria and bronchospasm.

The medicine contains sorbitol, patients with rare hereditary problems of fructose intolerance should not take this medicine. Fluifort 2.7 g / 10 ml syrup does not affect low-calorie or controlled diets and can also be administered to diabetic patients.

Fluifort 2.7 g / 10 ml syrup does not contain aspartame; therefore it can be administered to patients with phenylketonuria.

Fluifort 2.7 g / 10 ml syrup does not contain gluten; therefore it can be administered to patients with celiac disease.

Open the sachet following the dotted line and swallow the contents. [/ Su_spoiler]

[su_spoiler title = "INTERACTIONS"style =" fancy "icon =" chevron-circle "] In controlled clinical studies, no interactions with the most common drugs used in the treatment of upper and lower respiratory tract diseases, food and laboratory tests were highlighted. [ / su_spoiler]

[su_spoiler title = "FERTILITY, PREGNANCY AND BREASTFEEDING"style =" fancy "icon =" chevron-circle "] Although the active substance is neither teratogenic nor mutagenic and has not shown any negative effects on reproductive function in animals, Fluifort should not be administered during pregnancy (see 4.3). no data are available on the passage of carbocysteine lysine salt monohydrate into breast milk, use during lactation is contraindicated. [/ su_spoiler]

[su_spoiler title = "EFFECTS ON THE ABILITY TO DRIVE VEHICLES"style =" fancy "icon =" chevron-circle "] No adverse effects of the drug on the ability to drive or use machines have been reported. [/ su_spoiler]

[su_spoiler title = "SIDE EFFECTS"style =" fancy "icon =" chevron-circle "] The undesirable effects that can occur with Fluifort, classified by systems and organs (SOC), are the following:

Skin, subcutaneous tissue disorders: skin rash, urticaria, erythema, exanthema, rash / bullous erythema, pruritus, angioedema, dermatitis.

Gastrointestinal disorders: abdominal pain, nausea, vomiting, diarrhea.

Nervous system disorders: dizziness.

Respiratory, thoracic and mediastinal disorders: dyspnoea.

Vascular disorders: redness.

Bronchial obstruction can also occur with unknown frequency with mucolytics for oral and rectal use. [/ Su_spoiler]

[su_spoiler title = "OVERDOSE"style =" fancy "icon =" chevron-circle "] The symptoms reported in case of overdose are: headache, nausea, vomiting, diarrhea, stomach pain, skin reactions, alteration of the sensory systems.

There is no specific antidote; it is advisable to induce vomiting and possibly perform gastric lavage followed by specific support therapy. [/ su_spoiler]

[su_spoiler title = "LIST OF EXCIPIENTS"style =" fancy "icon =" chevron-circle "]

Sorbitol (solution 70%); xylitol; ammonium glycyrrhizinate; carmellose sodium; glycerol; cherry flavor; methyl para-hydroxybenzoate; propyl para-hydroxybenzoate; purified water. [/ su_spoiler]

[su_spoiler title = "STORAGE"style =" fancy "icon =" chevron-circle "] Store at a temperature below 25 ° C. If stored correctly, any change in color of the preparation does not affect the therapeutic activity of the specialty which remains valid until the expiry date indicated. [/ su_spoiler]

[su_spoiler title = "MARKETING AUTHORIZATION HOLDER"style =" fancy "icon =" chevron-circle "] Dompé pharmaceutici spa - Via San Martino, 12 - Milan. [/ su_spoiler]

[su_spoiler title = "AUTHORIZATION NUMBER - MINSAN"style =" fancy "icon =" chevron-circle "] 6 packets AIC n. 023834132 [/ su_spoiler]




































02383414
17 Items